» Authors » Ellie M Wekking

Ellie M Wekking

Explore the profile of Ellie M Wekking including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 254
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stiekema A, van Dam M, Bruggeman R, Redmeijer J, Swart M, Dethmers M, et al.
Schizophr Bull . 2020 Mar; 46(5):1259-1268. PMID: 32144418
Background: Feasible and effective interventions to improve daily functioning in people with a severe mental illness (SMI), such as schizophrenia, in need of longer-term rehabilitation are scarce. Aims: We assessed...
2.
van Valen E, van Hout E, Wekking E, Lenderink A, van der Laan G, Hageman G
Ned Tijdschr Geneeskd . 2016 Jan; 159:A9431. PMID: 26732212
Since 1997 more than 3,000 patients have been referred to one of the two Dutch Solvent Teams with health problems that may have been caused by long-term occupational exposure to...
3.
Verberk M, van der Hoek J, van Valen E, Wekking E, van Hout M, Hageman G, et al.
Neurotoxicology . 2012 Jun; 33(4):742-52. PMID: 22722000
For the diagnosis of patients suspected of chronic solvent-induced encephalopathy (CSE), it would be helpful if the applied cognitive tests show a characteristic profile of impairment in this disease. We...
4.
Wekking E, Bockting C, Koeter M, Schene A
J Affect Disord . 2012 May; 141(2-3):300-7. PMID: 22613451
Background: Cognitive impairment seems to persist during the euthymic phase of recurrent depression but its relationship with future relapses as with prior course of the disease has to be elucidated....
5.
van Hout M, Wekking E, Berg I, Deelman B
Psychother Psychosom . 2008 Jun; 77(5):289-97. PMID: 18560254
Background: There is little experience with the (neuro) psychological treatment of patients with solvent-induced chronic toxic encephalopathy (CSE). In this randomised controlled trial (RCT), a treatment programme was evaluated based...
6.
Van der Deure W, Appelhof B, Peeters R, Wiersinga W, Wekking E, Huyser J, et al.
Clin Endocrinol (Oxf) . 2008 Apr; 69(5):804-11. PMID: 18410547
Introduction: Some hypothyroid patients continue to have significant impairments in psychological well-being, despite adequate treatment with levothyroxine (LT4). T4 transport across the blood-brain barrier is one of the crucial processes...
7.
Wekking E, Appelhof B, Fliers E, Schene A, Huyser J, Tijssen J, et al.
Eur J Endocrinol . 2005 Dec; 153(6):747-53. PMID: 16322379
Objective: Hypothyroidism is associated with neurocognitive impairment. Sparse data suggest that treatment of hypothyroidism, resulting in a return to euthyroidism, may be associated with only partial recovery of overall neurocognitive...
8.
Appelhof B, Peeters R, Wiersinga W, Visser T, Wekking E, Huyser J, et al.
J Clin Endocrinol Metab . 2005 Sep; 90(11):6296-9. PMID: 16144953
Introduction: Some patients on levothyroxine replacement display significant impairment in psychological well-being, compared with sex- and age-matched controls. Levothyroxine-treated patients can be assumed to derive T3 exclusively from deiodination of...
9.
Appelhof B, Fliers E, Wekking E, Schene A, Huyser J, Tijssen J, et al.
J Clin Endocrinol Metab . 2005 Feb; 90(5):2666-74. PMID: 15705921
Controversy remains about the value of combined treatment with levothyroxine (LT4) and liothyronine (LT3), compared with LT4 alone in primary hypothyroidism. We compared combined treatment with LT4 and LT3 in...
10.
van Hout M, Wekking E, Berg I, Deelman B
Psychother Psychosom . 2003 Aug; 72(5):235-44. PMID: 12920327
Background: Chronic toxic encephalopathy (CTE), which can result from long-term exposure to organic solvents, is characterized by problems of attention and memory, fatigue and affective symptoms. There is little experience...